Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Camperdown
Clinical trial register · Australia

Clinical Trials in Camperdown, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Amgen18 AstraZeneca18 Janssen Research & Development, LLC17 Merck Sharp & Dohme LLC13 Hoffmann-La Roche11
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Camperdown

347 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Camperdown, Chermside, Greenslopes, South Brisbane, Adelaide, Frankston, Murdoch, Nedlands
2026-12-16
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Camperdown, Macquarie Park
2026-11-30
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Canberra, Camperdown, Wollongong, Chermside, Douglas, Milton, Rockhampton, Sippy Downs
2026-10-26
Not yet open
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
DrugsZL-1310·Obrixtamig·Atezolizumab
Boehringer Ingelheim
Phase 1/2
60
Camperdown
2026-10-19
Not yet open
Novo Nordisk A/S
Phase 3
84
Camperdown, Herston, Melbourne
2026-10-09
Recruiting
Boehringer Ingelheim
Phase 1/2
55
Camperdown, Douglas
2026-10-01
Recruiting
Biomed Industries, Inc.
Phase 3
210
Camperdown, South Brisbane, Heidelberg West, Parkville
2026-09-30
Recruiting
Bristol-Myers Squibb
Phase 3
850
Camperdown, Westmead, Greenslopes, Adelaide, Clayton, Murdoch
2026-09-08
Not yet open
AstraZeneca
Phase 3
750
Brisbane, Camperdown, Darlinghurst, Fitzroy, Melbourne, Nedlands
2026-08-25
Recruiting
Boehringer Ingelheim
Phase 3
600
Camperdown, Meadowbrook, Oaklands Park, Melbourne
2026-08-24
Recruiting
Gilead Sciences
Phase 2
120
Camperdown, St Leonards, Herston, Bedford Park, Nedlands
2026-08-07
Recruiting
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
NCT07713732Small Cell Lung Cancer ( SCLC ), Neuroendocrine Cancer, Malignant Pleural Mesotheliomas (Mpm), Synovial Sarcomas
DrugVenetoclax
Treeline Biosciences, Inc.
Phase 1
120
Camperdown, Malvern, Nedlands
2026-08-05
Recruiting
AstraZeneca
Phase 1/2
101
Camperdown, East Melbourne
2026-07-27
Recruiting
Verastem, Inc.
Phase 2
105
Camperdown, Sydney, Brisbane
2026-07-22
Recruiting
Insmed Incorporated
Phase 3
344
Camperdown, Westmead
2026-07-21
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Camperdown, Port Macquarie, Wollongong
2026-06-11
Recruiting
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
NCT07623525Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
Diagonal Therapeutics, Inc.
Phase 1/2
93
Camperdown, Randwick, Herston, East Melbourne, Parkville, West Perth
2026-06-04
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-22
Recruiting
Kite, A Gilead Company
Phase 3
550
Camperdown, Sydney, East Melbourne
2026-05-22
Recruiting
Gilead Sciences
Phase 2
170
Camperdown, Herston, Melbourne
2026-05-19
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Camperdown, Liverpool, Chemside, Woolloongabba, Clayton, Perth
2026-05-11
Not yet open
Vaccination Response Modulation With a Targeted Rapamycin Protocol Study
NCT07587801Vaccine Immune Response, Haemodialysis Patients, Older Adults
DrugsRSV Vaccine·Influenza vaccine·Rapamycin·Sirolimus
Central Adelaide Local Health Network Incorporated
Phase 2
60
Camperdown, Woolloongabba, Adelaide
2026-05
Recruiting
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
NCT07493512Metastatic Castration-resistant Prostate Cancer (mCRPC)
DrugXaluritamig
Amgen
Phase 1
40
Camperdown, Clayton
2026-04-28
Not yet open
Peter MacCallum Cancer Centre, Australia
Observational
75
Camperdown, Sydney, Adelaide, Hobart, Box Hill, Clayton, Melbourne, Nedlands
2026-04-08
Recruiting
Amgen
Phase 1
50
Camperdown, Melbourne, Nedlands
2026-04-08
Recruiting
University of Sydney
Not applicable
384
Camperdown, Brisbane
2026-04
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Blacktown, Camperdown, Meadowbrook, Oaklands Park, Heidelberg, Melbourne
2026-03-23
Recruiting
RECOMMEND Platform Trial
NCT06526533Extracorporeal Membrane Oxygenation Complication, ARDS (Acute Respiratory Distress Syndrome), Intensive Care Medicine, Cardiac Arrest (CA)
Australian and New Zealand Intensive Care Research Centre
Phase 3
600
Camperdown, Sydney, Melbourne
2026-03-23
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Camperdown, Westmead, Birtinya, Parkville
2026-03-16
Recruiting
Avalyn Pharma Inc.
Phase 2
160
Camperdown, Kingswood, Westmead
2026-03-10
Recruiting
Hoffmann-La Roche
Phase 2
360
Camperdown, Kogarah, New Lambton Heights, Box Hill, Heidelberg
2026-03-10
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Adelaide, Birtinya, Brisbane, Camperdown, Melbourne, Sydney
2026-03-01
Recruiting
AstraZeneca
Phase 3
508
Camperdown, Darlinghurst, Fitzroy, Liverpool, Melbourne, Murdoch
2026-02-23
Recruiting
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
NCT07349212Peanut-Induced Anaphylaxis, Peanut Allergy
Ukko Inc
Phase 1/2
40
Camperdown, Bedford Park, Fitzroy, Perth
2026-02-18
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
80
Camperdown, Chermside, Melbourne
2026-02-10
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
NCT06968845Idiopathic Pulmonary Fibrosis (IPF)
Rein Therapeutics
Phase 2
120
Camperdown, Westmead, Launceston, Box Hill
2026-02-02
Recruiting
Genmab
Phase 2
240
Adelaide, Camperdown, Hobart, Hyde Park, Murdoch, Saint Leonards
2026-01-30
Recruiting
Eikon Therapeutics
Phase 1/2
160
Saint Leonards, Waratah, Ballarat, Camperdown, Frankston
2026-01-20
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bedford Park, Camperdown, Heidelberg, Hobart, Liverpool, Melbourne, Nedlands, St Leonards
2026-01-16
Recruiting
Kahr Bio Australia Pty Ltd
Phase 2
90
Woodville, Camperdown, Port Macquarie, Westmead, South Brisbane, Bedford Park, Clayton, Footscray
2026-01-16
Recruiting
Novartis Pharmaceuticals
Phase 1/2
181
Camperdown, Wollongong
2026-01-13
Recruiting
Contineum Therapeutics
Phase 2
324
Camperdown, Westmead, Chermside, Greenslopes, Heidelberg, Melbourne, Midland, Spearwood
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Camperdown, Kingswood, New Lambton Heights, Westmead, Auchenflower, South Brisbane
2026-01-07
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Camperdown, Liverpool, St Leonards, Westmead, Birtinya, Brisbane, Adelaide, Elizabeth Vale
2025-12-31
Recruiting
AstraZeneca
Phase 3
1,100
Adelaide, Auchenflower, Campbelltown, Camperdown, Clayton, Cudgen, Garran, Gosford
2025-12-29
Recruiting
ArriVent BioPharma, Inc.
Phase 3
480
Blacktown, Camperdown, St Leonards, Heidelberg
2025-12-17
Recruiting
Ottimo Pharma Limited
Phase 1/2
170
Adelaide, Camperdown, Nedlands
2025-12-17
Recruiting
BeOne Medicines
Phase 1
86
Blacktown, Camperdown, Adelaide, Heidelberg, Melbourne
2025-12-11
Recruiting
AstraZeneca
Phase 2
230
Camperdown, Clayton, Herston, Melbourne, South Brisbane
2025-12-10
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder, Depression Disorders
DrugCYB003
Cybin IRL Limited
Phase 3
330
Camperdown, Maroochydore, Melbourne, Notting Hill
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Camperdown, Concors, Wollongong, South Brisbane, Townsville, Box Hill
2025-12-09
Recruiting
GlaxoSmithKline
Phase 3
450
Garran, Camperdown, Westmead, Melbourne
2025-12-03
Active, closed
Cochlear
Not applicable
36
Camperdown, Macquarie, Westmead, East Melbourne
2025-12-01
Recruiting
Genmab
Phase 3
660
Heidelberg, Campbelltown, Camperdown, Gosford, Kingswood, Waratah, Joondalup
2025-11-28
Recruiting
Kivu Bioscience Inc.
Phase 1
76
Camperdown, Sydney, Brisbane, Adelaide, Geelong
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Camperdown, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg, Melbourne
2025-11-12
Active, closed
Pfizer
Phase 2
42
Camperdown, Auchenflower
2025-11-10
Recruiting
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
NCT06819592All-cause Mortality, Quality of Life, Disability, Intellectual, Neurological Disorder
The George Institute
Phase 3
3,300
Canberra, Camperdown, Darlinghurst, Dubbo, Kingswood, Kogarah, Liverpool, Randwick
2025-10-30
Recruiting
Eli Lilly and Company
Phase 3
1,630
Ballarat Central, Camperdown, Launceston, Malvern, Randwick, Shepparton, Southport, St Leonards
2025-10-22
Recruiting
Amgen
Phase 1
60
Camperdown, Waratah, Clayton, Melbourne
2025-10-07
Recruiting
Janssen Research & Development, LLC
Phase 2
60
Camperdown, Clayton, Heidelberg, Murdoch, Woolloongabba
2025-10-03
Recruiting
AllRock Bio, Inc.
Phase 2
40
Camperdown, Auchenflower
2025-10-01
Recruiting
Bristol-Myers Squibb
Phase 2
182
Campbelltown, Camperdown, Woolloongabba, Adelaide
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Box Hill, Camperdown, Chermside, Elizabeth Vale, Frankston, Frenchs Forest, Heidelberg, Hobart
2025-09-08
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
125
Camperdown, Brisbane, Clayton
2025-09-04
Recruiting
University of Minnesota
Observational
1,500
Camperdown, Sydney, Westmead, Brisbane, Clayton, Heidelberg, Melbourne, Parkville
2025-08-25
Recruiting
Amgen
Phase 3
11,000
Garran, Camperdown, Charlestown, Concord, Merewether, Orange, Wollongong, Auchenflower
2025-08-22
Active, closed
Amgen
Phase 3
350
Camperdown, Clayton
2025-08-18
Recruiting
Novartis Pharmaceuticals
Phase 2
407
Camperdown, Kogarah, Box Hill, Heidelberg, Nedlands
2025-08-07
Active, closed
GlaxoSmithKline
Phase 2
168
Camperdown, Birtinya, Herston
2025-08-06
Recruiting
Amgen
Phase 1
434
Camperdown, Woodville South, Melbourne
2025-07-31
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Garran, Blactown, Burwood, Camperdown, Concord, Liverpool, New Lambton Heights, St Leonards
2025-07-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Blacktown, Camperdown, Clayton, Melbourne, Nedlands
2025-07-21
Recruiting
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT07075185Multiple Myeloma in Relapse, Myeloma Multiple, Multiple Myeloma Progression, Neoplasms by Histologic Type
Kelonia Therapeutics, Inc.
Phase 1
70
Camperdown, Melbourne
2025-07-16
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Camperdown, Darlinghurst, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg
2025-07-02
Not yet open
CPAP and Glucose Metabolism in Non-Diabetic OSA Subjects
NCT05335083Obstructive Sleep Apnea, Pre-diabetes
Woolcock Institute of Medical Research
Not applicable
100
Camperdown, Macquarie Park
2025-07-01
Recruiting
Cosmetique Active International
Not applicable
80
Camperdown
2025-07-01
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Camperdown, North Ryde, Westmead, Clayton
2025-06-30
Active, closed
Arrowhead Pharmaceuticals
Phase 3
70
Camperdown, Saint Leonards, Heidelberg, Nedlands
2025-06-17
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Recruiting
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,400
Camperdown, Gateshead, North Sydney, Westmead, Adelaide, Clayton, Melbourne
2025-06-06
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bedford Park, Camperdown, Fitzroy, Kogarah, Melbourne, Woolloongabba
2025-06-04
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Adelaide, Brisbane, Camperdown, Murdoch
2025-05-19
Recruiting
Dizal Pharmaceuticals
Phase 1
140
Blacktown, Camperdown
2025-05-13
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Camperdown, Westmead, Auchenflower, Melbourne
2025-05-12
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Blacktown, Camperdown, Kogarah, Waratah, South Brisbane, Melbourne, Perth
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Camperdown, Clayton, Heidelberg, Randwick, South Brisbane
2025-05-06
Recruiting
BioNTech SE
Phase 1/2
594
Camperdown, Bedford Park, Bendigo, Geelong, Saint Albans, Subiaco
2025-05-02
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329Progressive Pulmonary Fibrosis, Interstitial Lung Disease
University of Massachusetts, Worcester
Observational
500
Camperdown, Brisbane, Melbourne
2025-05-01
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.
Phase 2
340
Camperdown, Macquarie Park, Westmead, Brisbane, Woodville South, Melbourne, Chermside, Footscray
2025-04-17
Recruiting
University of Sydney
Not applicable
319
Camperdown
2025-04-15
Recruiting
Tissue Repair Gel in Venous Leg Ulcers in AU/US
NCT06707103Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis
DrugGlucoprime
TR Therapeutics
Phase 3
312
Camperdown, Kogarah, Orange, Sydney, Bendigo, Ivanhoe, Shepparton, Nedlands
2025-04
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2/3
150
Melbourne, Camperdown, Liverpool
2025-03-25
Recruiting
ROADMAP Clinical Trial
NCT06771050Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections
University of Newcastle, Australia
Phase 4
2,500
Garran, Bankstown, Blacktown, Campbelltown, Camperdown, Caringbah, Gateshead, Kingswood
2025-03-24
Recruiting
Bayer
Phase 1/2
450
Camperdown, Concord, Epping, Waratah
2025-03-21
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Camperdown, Liverpool, Brisbane, Adelaide, Clayton, Melbourne, Murdoch
2025-03-12
Active, closed
Takeda
Phase 3
601
Camperdown, Westmead, Sippy Downs, Woodville South, Palmyra Dc, Victoria Park
2025-03-10
Recruiting
Pikavation Therapeutics, Inc.
Phase 1/2
320
Camperdown, Randwick, Clayton, Melbourne, Nedlands
2025-02-20
Recruiting
Novo Nordisk A/S
Phase 3
510
Camperdown, Randwick, Clayton, Murdoch
2025-02-17
Recruiting
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
NCT06754852Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2, Von Willebrand Disease (VWD), Type 3
Hemab ApS
Phase 1/2
108
Murdoch, Camperdown, Melbourne
2025-02-06
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Camperdown, Kingswood, Waratah, Southport, Tugun, Heidelberg, North Melbourne, Murdoch
2025-01-28
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Camperdown, Penrith, St Leonards, Woolloongabba, Bedford Park, Hobart, Box Hill, Melbourne
2025-01-15
Recruiting
atai Therapeutics, Inc.
Phase 2
142
Camperdown, Carlton, Melbourne, Northcote, Parkville
2024-12-30
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Camperdown, Clayton, Murdoch, Wollongong
2024-12-13
Active, closed
Amgen
Phase 3
707
Camperdown, North Ryde, Woolloongabba, Clayton, Melbourne, Murdoch
2024-12-09
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Camperdown, Sydney, Melbourne
2024-12-09
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Camperdown, Macquarie Park, Brisbane, South Brisbane, Box Hill, Nedlands
2024-11-15
Active, closed
Alnylam Pharmaceuticals
Phase 1/2
89
Camperdown, Parkville
2024-11-07
Recruiting
A Study of DM005 in Patients With Advanced Solid Tumors
NCT06515990Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck, Solid Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd.
Phase 1/2
208
Camperdown, North Ryde, South Brisbane
2024-10-31
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Camperdown, Darlinghurst
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Camperdown, Darlinghurst, New Lambton Heights, Adelaide
2024-10-24
Active, closed
Ipsen
Observational
424
Camperdown, Fitzroy
2024-10-14
Recruiting
Amgen
Phase 1
220
Camperdown, Waratah, Melbourne
2024-10-07
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Garran, Camperdown, Westmead, Chermside, Adelaide, Heidelberg, Melbourne, Murdoch
2024-09-26
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
40
Camperdown, Clayton, St Leonards, Westmead, Wollongong, Woolloongabba, Bedford Park, Melbourne
2024-09-23
Active, closed
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
NCT06555796Prostate Cancer, High-risk Biochemical Recurrence, High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer, Non-metastatic Castration-sensitive Prostate Cancer
DrugXaluritamig
Amgen
Phase 1
50
Camperdown, Malvern, Melbourne
2024-09-23
Active, closed
Janssen Research & Development, LLC
Phase 2
11
Camperdown, Heidelberg, Melbourne
2024-09-16
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Camperdown, Herston, Adelaide, Melbourne
2024-09-11
Recruiting
Australia and New Zealand Sarcoma Association
Observational
100
Camperdown, Randwick, Melbourne
2024-09-05
Active, closed
Tectonic Therapeutic
Phase 2
191
Camperdown, Macquarie, New Lambton, Sydney, Wollongong, Chermside, Hobart, Malvern
2024-09-04
Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
NCT06610201Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2, Von Willebrand Disease (VWD), Type 3
Hemab ApS
Observational
200
Murdoch, Camperdown, Melbourne
2024-08-30
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Ballarat, Bendigo, Birtinya, Brisbane, Camperdown, Clayton, Concord, Garran
2024-08-30
Active, closed
Gilead Sciences
Phase 3
640
Canberra, Camperdown, South Brisbane, Clayton, Melbourne, Murdoch
2024-08-28
Active, closed
Kite, A Gilead Company
Phase 3
452
Camperdown, St Leonards, Adelaide, Richmond, Nedlands
2024-08-23
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Camperdown, Sydney, Melbourne
2024-08-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Camperdown, Clayton
2024-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Camperdown
2024-07-31
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-07-30
Recruiting
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
NCT06521554Locally Advanced Solid Tumor, Metastatic Solid Tumor
Nuvalent Inc.
Phase 1
200
Camperdown, Saint Leonards
2024-07-18
Recruiting
Amgen
Phase 3
450
Camperdown, Toowoomba, Woolloongabba, Bedford Park, Woodville South, Heidelberg
2024-07-17
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Camperdown, Fitzroy, Nedlands, Bedford Park, Woolloongabba
2024-07-09
Recruiting
Sanofi
Phase 1
96
Camperdown, Townsville, Adelaide, Melbourne, Perth
2024-07-08
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Camperdown, Birtinya, South Brisbane, City of Burnside, Box Hill, Southport
2024-06-25
Recruiting
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
NCT07491172Cardiovascular, Metabolic Disease, Dyslipidemias, Lipid Disorder
CRISPR Therapeutics AG
Phase 1
90
Adelaide, Brisbane, Camperdown, Heidelberg, Melbourne
2024-06-21
Recruiting
AstraZeneca
Phase 3
240
Camperdown, Nedlands, New Lambton, Southport, Woodville South
2024-06-20
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Bedford Park, Box Hill, Camperdown, Richmond
2024-06-07
Active, closed
Exelixis
Phase 2/3
600
Port Macquarie, Adelaide, Bedford Park, Camperdown, Murdoch
2024-06-07
Active, closed
Amgen
Phase 3
563
Camperdown, Wollongong, Greenslopes, Adelaide, Clayton, Nedlands
2024-06-05
Recruiting
The George Institute
Phase 4
162
Camperdown, Randwick, St Leonards, Warners Bay, Southport, Melbourne, Parkville
2024-06-03
Active, closed
Amgen
Phase 1
120
Camperdown, St Leonards, Woodville South, Heidelberg, Melbourne, St Albans
2024-05-29
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Brisbane, Camperdown, Randwick, Westmead
2024-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Camperdown, Urraween, Frankston, Nedlands
2024-05-24
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
NCT06351631Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis
DrugBomedemstat
Merck Sharp & Dohme LLC
Phase 3
400
Camperdown, St Leonards, Buderim, Southport, Adelaide, Clayton
2024-05-23
Recruiting
Daiichi Sankyo
Phase 3
540
Ballarat, Bedford Park, Camperdown, St Albans, Subiaco, Townsville, Woolloongabba
2024-05-21
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Camperdown, Westmead, Herston, Melbourne, Murdoch
2024-05-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-05-13
Active, closed
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
NCT06267391Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Diabetes
Endogenex, Inc.
Not applicable
350
Camperdown, Double Bay, Saint Leonards, Box Hill, Fitzroy, Heidelberg, Melbourne
2024-05-01
Recruiting
AstraZeneca
Phase 3
582
Camperdown, Clayton, Kogarah, South Brisbane, Westmead
2024-04-29
Active, closed
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
NCT06325748AML/MDS, CD33 Expressing Hematological Malignancies, FLT3 Expressing Hematological Malignancies
DrugFludarabine
Senti Biosciences
Phase 1
21
Camperdown, Melbourne
2024-04-22
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Camperdown, Kingswood, New Lambton, Sydney, Westmead, Nedlands, Brisbane, Footscray
2024-04-03
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
230
Camperdown, Brisbane, Melbourne
2024-03-21
Active, closed
AbbVie
Phase 1
152
Camperdown, Ballarat, Fitzroy
2024-03-08
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Camperdown, Chermside, Clayton, Hobart, Hyde Park
2024-02-26
Active, closed
Melanoma and Skin Cancer Trials Limited
Phase 3
146
Camperdown, Westmead, Chermside, Woolloongabba, Carlton, Melbourne
2024-02-09
Active, closed
Genmab
Phase 3
1,095
Camperdown, Liverpool, Melbourne, Westmead, Douglas, Herston, Woolloongabba, Frankston
2024-02-05
Recruiting
CSL Behring
Phase 3
35
Camperdown, Herston, Adelaide, Melbourne
2024-01-30
Active, closed
Bristol-Myers Squibb
Phase 4
63
Camperdown, Chermside, Melbourne
2024-01-24
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
DrugsElironrasib·RMC-9805·Cetuximab·Pemetrexed
Revolution Medicines, Inc.
Phase 1/2
616
Camperdown, Liverpool, St Leonards, Clayton, Nedlands
2024-01-18
Active, closed
DualityBio Inc.
Phase 3
541
Camperdown, Kingswood, Liverpool, Sydney, Birtinya, South Brisbane, Southport, Townsville
2024-01-18
Recruiting
Incyte Corporation
Phase 1
710
Camperdown, Darlinghurst, Melbourne, Nedlands
2024-01-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Camperdown, Liverpool, St Leonards, Waratah, Adelaide, Clayton, Melbourne, Perth
2023-12-31
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Camperdown, Birtinya, Brisbane, South Brisbane, Southport, West Mackay, Clayton, Perth
2023-12-11
Active, closed
AstraZeneca
Phase 3
760
Camperdown, Clayton, Murdoch, Westmead
2023-12-04
Recruiting
AstraZeneca
Phase 3
625
Camperdown, Darlinghurst, Heidelberg, Melbourne, Nedlands, Waratah
2023-11-23
By invitation
CRISPR Therapeutics AG
Observational
70
Camperdown, Melbourne, Nedlands, Richmond
2023-11-22
Active, closed
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
NCT06003231Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms, Head and Neck Neoplasms
DrugDisitamab Vedotin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
120
Camperdown, Macquarie University, Old Toongabie, Frankston, Blacktown
2023-11-14
Recruiting
AbbVie
Phase 1
325
Camperdown, Heidelberg
2023-11-09
Active, closed
Kite, A Gilead Company
Phase 1
21
Camperdown, South Brisbane, Melbourne
2023-11-09
Active, closed
Syntara
Phase 2
40
Macquarie, Camperdown
2023-11-08
Active, closed
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
NCT05784441Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1
21
Camperdown, Clayton, Heidelberg, Herston, Westmead
2023-11-06
Recruiting
United Therapeutics
Phase 3
698
Camperdown, Kogarah, Brisbane, Chermside, Box Hill, Clayton, Heidelberg, Midland
2023-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Heidelberg,VIC
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Blacktown, Camperdown, Coffs Harbour, Gold Coast, Clayton, Heidelberg
2023-10-24
Active, closed
Celgene
Phase 3
79
Camperdown, Brisbane, Melbourne, Murdoch
2023-10-16
Active, closed
Stichting European Myeloma Network
Phase 3
759
Brisbane, Camperdown, Herston, Melbourne, Murdoch, Waratah, Westmead
2023-10-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Bruce, Blacktown, Camperdown, Kanwal, Brisbane, Clayton, Hoppers Crossing
2023-10-09
Active, closed
Novartis Pharmaceuticals
Phase 3
109
Camperdown, Clayton, Melbourne, Nedlands
2023-10-02
Recruiting
The Florey Institute of Neuroscience and Mental Health
Phase 2
80
Camperdown, Liverpool, New Lambton Heights, Randwick, Adelaide, Box Hill, Parkville
2023-09-27
Recruiting
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NCT05814094Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication, Disability Physical, Cognitive Ability, General
Australian and New Zealand Intensive Care Research Centre
Not applicable
120
Camperdown, Sydney
2023-09-20
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Camperdown, St Leonards, Auchenflower, Herston, Adelaide, Hobart, Launceston, Fitzroy
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Frankston
2023-09-14
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Camperdown, Liverpool, Adelaide, Woodville South, Fitzroy
2023-09-13
Recruiting
Inipharm Australia Pty Ltd
Phase 1
168
Camperdown, Campbelltown, Newcastle, Saint Leonards, Woolloongabba, Birtinya, Bedford Park, Box Hill
2023-09-08
By invitation
Disc Medicine, Inc
Phase 2/3
230
Camperdown, Parkville
2023-08-31
Recruiting
DualityBio Inc.
Phase 1/2
862
Blacktown, Camperdown, Concord, New Lambton Heights, Sydney, Waratah, Birtinya, Brisbane
2023-08-17
Recruiting
Genentech, Inc.
Phase 1
120
Camperdown, Waratah, Adelaide, Melbourne, Prahan
2023-08-10
Recruiting
Kirby Institute
Phase 3
320
Blacktown, Camperdown, Concord, Darlinghurst, Westmead
2023-07-21
Active, closed
MapLight Therapeutics
Phase 2
120
Camperdown, Parkville
2023-06-01
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Camperdown, Randwick, Westmead, Melbourne
2023-05-09
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Camperdown, Kingswood, Wollongong, Bedford Park, Darlinghurst, Bendigo, Frankston, Geelong
2023-04-30
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
500
Garran, Camperdown, Caringbah, Darlinghurst, Gosford, Kingswood, Orange, Saint Leonards
2023-04-26
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Randwick, Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
2023-04-25
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Albury, Campbelltown, Camperdown, Gosford, New Lambton Heights, Saint Leonards, Wentworthville, Southport
2023-04-18
Recruiting
AUM Biosciences Pte Ltd
Phase 2
120
Camperdown, Wollongong, Benowa, Malvern, Wendouree
2023-04-14
Active, closed
Bayer
Phase 3
985
Camperdown, Epping, Liverpool, Wahroonga, Adelaide, Box Hill, East Melbourne, Geelong
2023-04-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Camperdown, Westmead, Auchenflower, Brisbane, South Brisbane
2023-03-16
Recruiting
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
NCT05643742B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
DrugZugo-cel
CRISPR Therapeutics AG
Phase 1/2
120
Camperdown, Melbourne, Nedlands
2023-03-10
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Garran, Camperdown, Concord, Auchenflower, Sippy Downs, Woolloongabba, Adelaide, Leabrook
2023-03-09
Active, closed
BeiGene
Phase 2
400
Blacktown, Camperdown, Frenchs Forest, Port Macquarie, Nedlands, Subiaco
2023-03-07
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Adelaide, Box Hill, Campbelltown, Camperdown, Clayton, Fitzroy, Heidelberg, Herston
2023-02-15
Active, closed
Kite, A Gilead Company
Phase 3
300
Camperdown, South Brisbane, Melbourne
2023-02-10
Active, closed
Bristol-Myers Squibb
Phase 3
606
Camperdown, Gosford, Port Macquarie, St Leonards, Sydney, Adelaide, Bendigo, East Melbourne
2023-01-10
Active, closed
Exelixis
Phase 3
317
Albury, Camperdown, Liverpool, Macquarie, Sydney, Waratah, Douglas, Elizabeth Vale
2023-01-01
Recruiting
Pfizer
Phase 3
173
Camperdown, Melbourne
2022-12-28
Recruiting
University of Michigan Rogel Cancer Center
Observational
200
Camperdown, Melbourne
2022-12-22
Active, closed
Amgen
Phase 3
7,297
Garran, Camperdown, Concord, Liverpool, Sydney, Wollongong, Auchenflower, Bundaberg
2022-12-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Saint Leonards, Adelaide, Camperdown, Clayton, Woolloongabba
2022-12-13
Active, closed
AbbVie
Phase 1
288
Camperdown, Darlinghurst, Heidelberg, Melbourne
2022-12-05
Recruiting
Leiden University Medical Center
Phase 2
168
Albury, Camperdown, Kogarah, Newcastle, St Leonards, Wahroonga, Birtinya, South Brisbane
2022-11-10
Recruiting
Pfizer
Phase 3
1,060
Camperdown, Benowa, Fitzroy, Melbourne, Richmond
2022-11-10
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Camperdown, Chermside, Melbourne, Nedlands, Parkville, South Brisbane, Westmead
2022-11-08
Recruiting
Arcus Biosciences, Inc.
Phase 1
362
Camperdown, Melbourne, Sydney
2022-10-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Camperdown, Geelong, Liverpool, Nedlands, New South Wales, Wollongong, Woolloongabba
2022-10-25
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Camperdown, Woolloongabba, Fitzroy
2022-10-24
Active, closed
Genmab
Phase 3
549
Camperdown, Kingswood, Douglas, Frankston, Murdoch, Perth
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Box Hill, Camperdown, Clayton, Concord, Footscray, Maroochydore, Murdoch, North Terrace
2022-09-19
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
NCT05519449Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Castration Resistant Prostatic Cancer
DrugsJANX007·Darolutamide
Janux Therapeutics
Phase 1
272
Camperdown, Bedford Park, Nedlands
2022-09-15
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Clayton, Herston, Murdoch, Parkville, South Brisbane, Woodville South
2022-09-13
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Camperdown, Macquarie Park, Westmead, Cairns, Chermside, South Brisbane, Melbourne
2022-09-06
Active, closed
Hoffmann-La Roche
Phase 3
132
Camperdown, Clayton, Nedlands
2022-08-30
Active, closed
Amgen
Phase 1
184
Camperdown
2022-08-24
Active, closed
Biogen
Phase 2
416
Camperdown, Darlinghurst, Kogarah, Liverpool, South Brisbane
2022-08-24
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Melbourne, Murdoch, Westmead, Woolloongabba
2022-08-05
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Camperdown, Westmead
2022-08-03
Active, closed
Daiichi Sankyo
Phase 3
586
Camperdown, Kogarah, Liverpool, Melbourne, Subiaco, Woolloongabba
2022-07-08
Recruiting
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
NCT05025813Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Cancer
DrugPembrolizumab
Queensland Health
Phase 2
27
Camperdown, Herston, Woolloongabba
2022-06-28
Active, closed
Cogent Biosciences, Inc.
Phase 2
237
Camperdown, Adelaide
2022-06-27
Active, closed
AstraZeneca
Phase 1/2
174
Camperdown, Darlinghurst, East Melbourne, Heidelberg, Melbourne, St Leonards
2022-06-02
Active, closed
Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation
NCT05003609Extracorporeal Membrane Oxygenation Complication
Australian and New Zealand Intensive Care Research Centre
Not applicable
100
Camperdown, Darlinghurst, Chermside, Woolloongabba, Melbourne, Murdoch
2022-04-27
Active, closed
Eli Lilly and Company
Phase 3
925
Camperdown, Coffs Harbour, Darlinghurst, Liverpool, Macquarie University, South Brisbane, Southport, Woolloongabba
2022-04-14
Active, closed
Pfizer
Phase 3
854
Camperdown, Nowra, Westmead, Wollongong, Benowa, Clayfield, Woolloongabba, East Melbourne
2022-03-25
Recruiting
ORIC Pharmaceuticals
Phase 1/2
350
Camperdown, Melbourne, Nedlands, Sydney
2022-03-10
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Camperdown, Macquarie University, Westmead, Adelaide, Bedford Park, Box Hill, Heidelberg, Subiaco
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Heidelberg, Mount Waverley, Camperdown, Woodville South
2022-03-04
Recruiting
Eledon Pharmaceuticals
Phase 1/2
48
Camperdown, Adelaide
2022-02-18
Recruiting
University of Melbourne
Phase 4
8,000
Garran, Blacktown, Camperdown, Concord, Darlinghurst, Kingswood, Kogarah, Liverpool
2022-02-16
Active, closed
BioMarin Pharmaceutical
Phase 1/2
44
Camperdown
2022-02-15
Active, closed
Amgen
Phase 1/2
329
Camperdown, East Melbourne, Parkville
2022-02-01
Recruiting
Nuvalent Inc.
Phase 1/2
359
Camperdown, Melbourne
2022-01-04
Recruiting
Concord Repatriation General Hospital
Not applicable
476
Camperdown, Concord, Gosford, Randwick, Westmead, Brisbane, Fitzroy, Heidelberg
2022-01
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Camperdown, Liverpool, Westmead, Clayton
2021-12-17
Active, closed
Amgen
Phase 3
303
Garran, Camperdown, Liverpool, St Leonards, Westmead, Herston, Woolloongabba, Adelaide
2021-11-02
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Adelaide, Camperdown, Randwick, Westmead, Southport, Bedford Park, Clayton, Fitzroy
2021-11-01
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
1,000
Bankstown, Camperdown, Kingswood, New Lambton Heights, Port Macquarie, Sydney, Tamworth, Westmead
2021-10-26
Recruiting
University of Sydney
Phase 3
445
Bankstown, Camperdown, Concord, Frenchs Forest, Liverpool, New Lambton Heights, Randwick, Wollongong
2021-10-14
Active, closed
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT05059262Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 3
123
Camperdown
2021-10-14
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Adelaide, Camperdown, Woolloongabba
2021-09-23
Active, closed
Immunome, Inc.
Phase 2/3
198
Camperdown, Woolloongabba, Kurralta Park, Melbourne
2021-09-01
Active, closed
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
NCT05020678Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma
DrugNKX019
Nkarta, Inc.
Phase 1
150
Camperdown, Sydney, Brisbane, Melbourne
2021-08-20
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Camperdown, Fitzroy, Heidelberg, Herston, Melbourne, Murdoch, Waratah, Westmead
2021-08-19
Active, closed
Gilead Sciences
Phase 1
304
Camperdown, Clayton, Melbourne
2021-08-18
Active, closed
Akeso
Phase 3
296
Camperdown, Darlinghurst, St Leonards, Heidelberg, Nedlands
2021-08-16
Active, closed
GlaxoSmithKline
Phase 3
40
Camperdown, Macquarie Park, North Sydney
2021-06-28
Active, closed
Biogen
Phase 3
548
Camperdown, Box Hill, Footscray, Murdoch
2021-05-25
Active, closed
Savara Inc.
Phase 3
164
Camperdown, Westmead
2021-05-19
Active, closed
Pfizer
Phase 3
599
Camperdown, Wollongong, Brisbane, Southport, Woodville South, East Melbourne, Malvern, Richmond
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Camperdown, Chermside, Darlinghurst, New Lambton Heights, Adelaide, Hobart, Murdoch
2021-05-12
Active, closed
Hoffmann-La Roche
Observational
800
Camperdown, Liverpool, St Leonards, Bedford Park, East Melbourne
2021-05-10
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Camperdown, Kingswood, Liverpool, Westmead, Southport, Adelaide, Elizabeth Vale, Fitzroy
2021-04-01
Active, closed
Melanoma and Skin Cancer Trials Limited
Not applicable
670
Camperdown, Newcastle, Sydney, Wollstonecraft, Brisbane, Cairns, Townsville, Bendigo
2021-03-03
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Camperdown, Westmead, South Brisbane, Murdoch
2021-02-23
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Blacktown, Camperdown, Kogarah, Melbourne, Subiaco, Woolloongabba
2021-02-02
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
250
Woolloongabba, Melbourne, Camperdown
2021-01-20
Recruiting
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Queensland Centre for Gynaecological Cancer
Phase 3
760
Camperdown, Liverpool, Auchenflower, Brisbane, Buderim, Everton Park, Herston, South Brisbane
2021-01-18
Active, closed
Pfizer
Phase 3
841
Camperdown, Liverpool, St Leonards, Herston, Woolloongabba, Adelaide, Clayton, Heidelberg
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
1,600
Adelaide, Camperdown, Clayton, Heidelberg, Melbourne, Nedlands, Saint Leonards, Subiaco
2020-12-04
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPrifetrastat·Atirmociclib·Palbociclib·Letrozole
Pfizer
Phase 2
320
Camperdown, Adelaide, Melbourne, Parkville, St Albans, Subiaco
2020-11-16
Active, closed
The ENCIRCLE Trial
NCT04153292Mitral Regurgitation, Mitral Valve Insufficiency
Edwards Lifesciences
Not applicable
786
Chermside, Camperdown
2020-11-12
Recruiting
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
NCT04588311Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries
DrugEpoetin Alfa
Australian and New Zealand Intensive Care Research Centre
Phase 3
2,500
Camperdown, Darlinghurst, Kogarah, Liverpool, New Lambton Heights, Saint Leonards, Westmead, Tiwi
2020-11-09
Active, closed
Prevail Therapeutics
Phase 1/2
35
Camperdown
2020-11-09
Active, closed
Erasmus Medical Center
Observational
600
Camperdown
2020-11-01
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
DrugsRezatapopt·Keytruda·Pembrolizumab
PMV Pharmaceuticals, Inc
Phase 1/2
300
Camperdown, South Brisbane, Bedford Park, Clayton, Nedlands
2020-10-29
Active, closed
Hoffmann-La Roche
Phase 3
985
Camperdown, Liverpool, New Lambton, Woolloongabba, Box Hill, Heidelberg, Parkville
2020-10-26
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Camperdown, Kogarah, Malvern, Nedlands
2020-10-13
Active, closed
Acerta Pharma BV
Phase 3
611
Adelaide, Camperdown, Darlinghurst, Heidelberg, Hobart, Kogarah, Nedlands, Westmead
2020-10-08
Active, closed
AstraZeneca
Phase 3
370
Camperdown, Elizabeth Vale, Heidelberg, Melbourne
2020-10-02
Recruiting
University of Birmingham
Phase 1/2
1,672
Brisbane, Camperdown, Clayton, Melbourne, New Lambton Heights, Perth, Sydney, Westmead
2020-09-17
Recruiting
Nordic Lymphoma Group
Phase 3
300
Albury, Camperdown, Coffs Harbour, Concord, Cudgen, Garran, Hobart, Liverpool
2020-08-19
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Auchenflower, Blacktown, Camperdown, Heidelberg, Melbourne, Nedlands
2020-08-18
Active, closed
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
162
Camperdown, Darlinghurst, Kogarah, Liverpool, Macquarie Park, Newcastle, Sydney, Brisbane
2020-08-17
Active, closed
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
NCT05524077Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated, Sarcoidosis
Western Sydney Local Health District
Not applicable
162
Camperdown, Kingswood, New Lambton Heights, Saint Leonards, Westmead, Chermside, Southport, Adelaide
2020-07-08
Active, closed
Actelion
Phase 3
935
Bedford Park, Camperdown, Chermside, Darlinghurst, Hobart, Murdoch, Westmead
2020-06-30
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Adelaide, Camperdown, Herston, Melbourne, Murdoch
2020-06-12
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
NCT04429542Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, Colorectal Cancer, Squamous Cell Carcinoma of the Lung
DrugPembrolizumab
Bicara Therapeutics
Phase 1
473
Camperdown, Waratah, Heidelberg, Melbourne
2020-06-01
Recruiting
Amgen
Phase 1
479
Camperdown, Clayton
2020-03-04
Active, closed
Eli Lilly and Company
Phase 3
261
Camperdown, Waratah, Westmead, Clayton, Melbourne, Frankston
2020-02-17
By invitation
The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
NCT05298982Critically Ill, Mechanical Ventilation, Long Term Outcome
Australian and New Zealand Intensive Care Research Centre
Observational
250
Camperdown, Sydney, Wollongong, Birtinya, Brisbane, Caboolture, Redcliffe, Toowoomba
2020-02-11
Recruiting
Eli Lilly and Company
Phase 2
105
Camperdown, Melbourne
2020-01-22
Active, closed
Pfizer
Phase 3
1,068
Bowral, Camperdown, Box Hill, Lilydale
2019-12-30
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Adelaide, Brisbane, Camperdown, Douglas, Geelong, Gosford, Hobart, Melbourne
2019-12-20
Recruiting
The University of Queensland
Not applicable
3,600
Camperdown, Kingswood, Kogarah, Saint Leonards, Westmead, Wollongong, Birtinya, Brisbane
2019-12-10
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Camperdown, Wollongong, Southport, Clayton, Melbourne, Nedlands
2019-10-08
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Camperdown, Darlinghurst, Sydney, Chermside, Woolloongabba, Hobart, Fitzroy, Melbourne
2019-09-23
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
Camperdown, Kogarah, Liverpool, Melbourne, Murdoch, Nedlands
2019-09-06
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Camperdown, Heidelberg, Parkville
2019-08-12
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
South Brisbane, Adelaide, Clayton, Camperdown
2019-08-12
Active, closed
Pfizer
Phase 3
51
Camperdown, Adelaide, Melbourne, Murdoch, Herston
2019-07-29
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Blacktown, Camperdown, Heidelberg, Kogarah, North Melbourne, Perth, Wollongong
2019-07-09
Active, closed
AstraZeneca
Phase 3
587
Camperdown, Chermside, Elizabeth Vale, Heidelberg, Kogarah, Melbourne
2019-07-02
Recruiting
Population Health Research Institute
Phase 4
2,270
Garran, Bankstown, Camperdown, Concord, Liverpool, Newcastle, Westmead, Birtinya
2019-06-14
Recruiting
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347Fetal Growth Retardation, Stillbirth and Fetal Death, Pregnancy Preterm
DrugMelatonin
Monash University
Phase 3
336
Camperdown, Newcastle, South Brisbane, Southport, North Adelaide, Clayton, Heidelberg, Parkville
2019-05-29
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Camperdown, Darlinghurst, Kingswood, New Lambton, Westmead, Herston, South Brisbane, Adelaide
2019-03-28
Recruiting
Imugene Limited
Phase 1
135
Camperdown, Liverpool, Adelaide, Fitzroy, Geelong
2019-03-11
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Adelaide, Brisbane, Camperdown, Canberra, Douglas, Hobart, Launceston, Melbourne
2019-03-01
Active, closed
AbbVie
Phase 1
364
Camperdown, South Brisbane
2019-02-21
Recruiting
The EXCEL Registry of Patients Requiring ECMO
NCT03793257Critically Ill, Acute Respiratory Failure, Acute Heart Failure, Cardiac Arrest
Australian and New Zealand Intensive Care Research Centre
Observational
3,000
Canberra, Camperdown, Darlinghurst, Liverpool, Newcastle, St Leonards, Sydney, Westmead
2019-02-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Camperdown, Sydney, South Brisbane, Frankston, Melbourne
2018-12-27
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Camperdown
2018-12-01
Active, closed
AstraZeneca
Phase 3
724
Benowa, Box Hill, Camperdown, Clayton, Herston, Liverpool, Melbourne
2018-11-30
Active, closed
Eli Lilly and Company
Phase 2/3
393
Camperdown, Kogarah, Macquarie University, Randwick, Melbourne
2018-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Camperdown, Liverpool, Macquarie University, North Sydney, Orange, Port Macquarie, St Leonards, Waratah
2018-08-21
Active, closed
Hoffmann-La Roche
Phase 3
257
Camperdown, St Leonards, Melbourne
2018-08-16
Active, closed
Canadian Cancer Trials Group
Phase 2
117
Camperdown, Randwick, Westmead, Melbourne, Subiaco
2018-07-24
Recruiting
Celgene
Phase 2/3
1,541
Camperdown, Melbourne, Murdoch
2018-07-19
Active, closed
Exelixis
Phase 3
837
Camperdown, Darlinghurst, Kingswood, Kogarah, Westmead, Greenslopes, Kurralta Park, Box Hill
2018-06-10
Active, closed
Bristol-Myers Squibb
Phase 3
545
Blacktown, Camperdown, Concord, Herston, Adelaide, Heidelberg, Nedlands
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Camperdown, Frankston, Kogarah, Melbourne, Murdoch
2018-03-23
Active, closed
University of Sydney
Phase 2
103
Campbelltown, Camperdown, Gosford, New Lambton Heights, Port Macquarie, Randwick, Saint Leonards, Wollongong
2018-02-22
Active, closed
Amgen
Phase 1
269
Camperdown
2017-12-26
Recruiting
University of Alberta
Observational
300
Camperdown
2017-12-19
Active, closed
Pfizer
Phase 3
1,054
Camperdown, Darlinghurst, Port Macquarie, Auchenflower, Brisbane, Chermside, South Brisbane, Southport
2017-12-18
Active, closed
Hoffmann-La Roche
Phase 3
382
Camperdown, Woolloongabba
2017-09-20
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Albury, Camperdown, Gosford, North Ryde, Randwick, St Albans
2017-09-05
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Canberra, Campbelltown, Camperdown, Darlinghurst, Gateshead, Gosford, Liverpool, Newcastle
2017-08-21
Active, closed
Sarcoma Alliance for Research through Collaboration
Phase 2
126
Camperdown, Brisbane, Melbourne
2017-07-19
Active, closed
Eli Lilly and Company
Phase 3
5,637
Camperdown, Darlinghurst, Lismore, Liverpool, Sydney, Waratah, Westmead, Wollongong
2017-07-12
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Camperdown, Adelaide, Bedford Park
2017-06-26
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Camperdown, Adelaide, Melbourne, East Melbourne
2017-03-07
Active, closed
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
NCT01320345Type 1 Diabetes Mellitus, Diabetic Retinopathy, Diabetic Nephropathies
DrugFenofibrate
University of Sydney
Phase 3
412
Garran, Camperdown, Concord, Darlinghurst, Liverpool, Merewether, Randwick, Saint Leonards
2016-11-03
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Albury, Camperdown
2016-06
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Camperdown, Heidelberg, Kogarah, Murdoch, Woolloongabba
2016-05-24
Active, closed
AbbVie
Phase 3
1,629
Camperdown, Camberwell
2015-12-01
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Camperdown, Melbourne, Parkville, Murdoch, Herston
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
Bedford Park, Camperdown, Darlinghurst, Heidelberg, Kogarah, Kurralta Park, Woolloongabba
2015-10-21
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Camperdown, Woolloongabba, Box Hill, Melbourne
2015-08-06
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Adelaide, Ashford, Camperdown, Herston, Liverpool, Malvern, Melbourne, Southport
2014-11-26
Active, closed
Eli Lilly and Company
Phase 3
493
Camperdown, Sydney, Wahroonga, South Brisbane, Woolloongabba, Woodville, Geelong, Murdoch
2014-11-06
Active, closed
University of Sydney
Phase 3
1,125
Camperdown, Coffs Harbour, Concord, Darlinghurst, Kingswood, Kogarah, Orange, Port Macquarie
2014-03
Active, closed
University of Sydney
Phase 3
802
Blacktown, Campbelltown, Camperdown, Gateshead, Gosford, Kogarah, Liverpool, Orange
2014-03
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Adelaide, Box Hill, Camperdown, Darlinghurst, Geelong, Gosford, Hobart, Kogarah
2013-10-14
Active, closed
AstraZeneca
Phase 3
510
Camperdown, Chermside, Darlinghurst, Fitzroy, Kogarah, Kurralta Park, Malvern, Wendouree
2013-09-25
Active, closed
AbbVie
Observational
8,250
Garran, Camperdown, Concord, East Lismore, New Lambton, Herston, South Brisbane, Adelaide
2013-04-29
Active, closed
Improving the Treatment for Women With Early Stage Cancer of the Uterus
NCT01686126Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma
DrugsLevonorgestrel·Mirena·Metformin
Queensland Centre for Gynaecological Cancer
Phase 2
165
Camperdown, Auchenflower, Brisbane, Greenslopes, South Brisbane, Southport, Townsville, Adelaide
2012-12
Active, closed
W.L.Gore & Associates
Observational
4,600
Camperdown
2010-12
Active, closed
Trans Tasman Radiation Oncology Group
Not applicable
333
Campbelltown, Camperdown, Coffs Harbour, Darlinghurst, Kingswood, Kogarah, Liverpool, Newcastle
2009-03-03
Rows per page Showing 1–347 of 347
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/camperdown

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 347 of those studies with a site in Camperdown.

How many clinical trials are recruiting in Camperdown?

167 of the 347 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 8 have not yet opened recruitment, 164 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Camperdown), 347 studies
PhaseStudiesRecruitingShare
Phase 31716649.3%
Phase 2552715.9%
Phase 1412511.8%
Phase 1/231248.9%
Not applicable1895.2%
Observational1684.6%
Phase 2/31042.9%
Phase 4541.4%

Most active sponsors

Lead sponsors with the most studies (Camperdown)
Lead sponsorStudiesRecruiting
Amgen188
AstraZeneca189
Janssen Research & Development, LLC175
Merck Sharp & Dohme LLC136
Bristol-Myers Squibb114
Hoffmann-La Roche114
Pfizer103
Novartis Pharmaceuticals94
Australian and New Zealand Intensive Care Research Centre84
AbbVie71
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.